Pharma Export Readiness Assessment (TDAP): What It Covers and How Pakistani Companies Can Prepare

on
Pharma export readiness assessment by TDAP showing a scorecard for GMP, dossier, quality and supply chain

Pharma Export Readiness Assessment (TDAP): What It Covers and How Pakistani Companies Can Prepare

Quick answer: The Export Readiness Assessment (ERA) is a structured evaluation offered on the Pakistan Pharma Trade Portal to help pharmaceutical companies understand their current capabilities and identify gaps against international export requirements. Afterwards, companies receive a customised Export Roadmap.

🧭 What is the Export Readiness Assessment?

Before a company ships medicines abroad, it needs to know whether its factory, paperwork and business systems meet the standards of the target market. The portal describes the ERA as a way to evaluate your company's readiness to export pharmaceutical products to international markets. It is one of the facilitation services on the portal, together with Pharma Consultation and B2B Match Making.

🔍 What the Assessment Covers

The portal says the ERA covers five areas, and highlights three focus points on the page:

Area What it looks at (as described by the portal)
🏭 GMP complianceFacility compliance against WHO, EU and US-FDA GMP standards
📄 Regulatory dossier readinessCompleteness of your CTD dossier for target markets
✅ Quality management systemsHow well your quality systems are set up
🚚 Supply chain capabilitiesYour ability to deliver reliably
💼 Commercial readinessYour readiness to sell and serve international customers
📊 BenchmarkingPakistan's pharma export performance compared with international standards, best practices and top exporting nations

CTD stands for Common Technical Document, a standard format for submitting medicine registration dossiers. The portal does not explain how scores are calculated, so ask TDAP how your assessment will be conducted.

🗺️ Your Export Roadmap and Post-Assessment Support

After the assessment, the portal says companies receive a customised Export Roadmap that outlines:

  • 🪜 The steps needed to become export-ready for your target markets
  • ⏱️ A timeline
  • 💰 Estimated costs

TDAP then links companies with:

  • 🛠️ Appropriate technical assistance programmes
  • 🏦 Financing options
  • 🧑‍⚕️ Regulatory consultants to help implement the roadmap
🔁 Follow-up: The portal says follow-up assessments are available after 12 months to measure your progress. Treat the first assessment as a baseline.

📝 How to Get Started

The ERA page describes the programme but does not publish a step-by-step application process. The portal's homepage lists "Export Readiness Assessment" among its facilitation services, with a "Start assessment" link. A sensible starting path, based on how the portal is organised, is:

  1. Register your company on the Pakistan Pharma Trade Portal.
  2. Log in and look for the Export Readiness Assessment under Facilitation.
  3. Follow the on-screen instructions, or contact the TDAP Help Desk if you cannot find the option.

Need help with company paperwork first? See our guides on company registration with SECP and the FBR IRIS login.

✅ A Simple Self-Check Before You Apply

This checklist is my own general suggestion, not an official TDAP form. It helps you walk into the assessment better prepared:

  • ☐ Do you have a valid DRAP licence and up-to-date manufacturing certificates?
  • ☐ Have you picked one or two target markets and a product list?
  • ☐ Do you know which GMP standard (WHO, EU or US-FDA) that market expects?
  • ☐ Is your dossier drafted in CTD format, or at least well organised?
  • ☐ Are your quality procedures and records documented and current?
  • ☐ Can you supply consistent volumes with proper packaging and logistics?
  • ☐ Do you have export pricing, trade terms and a point person for buyers?

🚀 Where It Fits in Your Export Journey

  1. Assess: take the Export Readiness Assessment to find your gaps.
  2. Plan: follow your Export Roadmap and get regulatory advice from the consultation service.
  3. Prepare: fix GMP and dossier gaps and strengthen quality and supply systems.
  4. Meet buyers: join B2B sessions and exhibitions.
  5. Review: use the 12-month follow-up to measure progress.

🔗 Related Guides on Our Blog

❓ Frequently Asked Questions (FAQs)

What is the Export Readiness Assessment?

It is a structured TDAP evaluation that helps pharma companies understand their current capabilities and identify gaps against international export requirements.

What does it cover?

GMP compliance, regulatory dossier readiness, quality management systems, supply chain capabilities and commercial readiness.

What do I get after the assessment?

A customised Export Roadmap with steps, a timeline and estimated costs, plus links to technical assistance, financing options and regulatory consultants.

Can I be assessed again?

The portal says follow-up assessments are available after 12 months to measure progress.

What does it cost?

The ERA page does not state any fee. Ask TDAP or check the portal for current terms.

🎯 Conclusion

The Pharma Export Readiness Assessment turns a vague goal like "we want to export" into a clear plan. It checks your GMP, dossier, quality, supply chain and commercial readiness, then gives you a roadmap with costs and timelines. Register on the portal, prepare your documents and use the results to guide your next steps. Questions? Share them in the comments!

For video guide, view this video

Disclaimer: This article is for general information only and is not legal, regulatory or professional advice. This blog is not affiliated with the Trade Development Authority of Pakistan, DRAP or the Government of Pakistan. Programme details, fees and procedures change, so please verify everything on the official portal before applying.

🏷️ Tags: #ExportReadiness #PharmaExports #TDAP #GMPCompliance #ExportRoadmap

Location: Pakistan

Comments

Post a Comment